BioTime Reports Interim Results on Reneviaa Clinical Safety Trial

BioTime, Inc. , today announced that William Tew, Ph.D., BioTime's Chief Commercial Officer will provide an update on the development of Renevia a at an investor meeting in New York City.

http://www.businesswire.com/news/topix/20131028005633/en